COV Covalon Technologies Ltd.

TSXV · CA · Healthcare · Medical Instruments & Supplies · covalon.com

3.820CAD-5.68%Mkt Cap: 76.83M $P/E: 23.881d ago

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap76.83M USD

Enterprise Value68.57M USD

Revenue (TTM)25.01M USD

Gross Profit12.72M USD

Net Income (TTM)1.50M USD

Revenue/Share1.25 CAD

Last Price3.820 CAD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees—

CountryCA

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINCA22282D3022

Valuation

P/E (Trailing)23.88

P/E (Forward)20.25

PEG—

EV/EBITDA23.23

EV/Revenue2.74

P/S3.26

P/B3.55

EPS (TTM)0.16

EPS (Forward)0.20

52W Range

1.55075% of range4.590

52W High4.590 CAD

52W Low1.550 CAD

Profitability

Gross Margin53.24%

Oper. Margin27.16%

EBITDA Margin11.80%

Profit Margin6.27%

ROE6.70%

ROA5.70%

Growth

Revenue Growth19.90%

Earnings Growth4225.30%

Cash Flow & Leverage

Operating CF1.67M USD

CapEx (TTM)616.85K USD

FCF Margin8.56%

FCF Yield2.79%

Net Debt-12.89M USD

Net Debt/EBITDA-4.37

Balance Sheet

Debt/Equity0.07

Current Ratio8.56

Quick Ratio6.51

Book Value/Sh1.14 CAD

Cash/Share0.70 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div DateNov 4, 2025

Pay DateNov 18, 2025

Splits

Last Split1:10

Split DateJul 16, 2013

Analyst Consensus

Rating—

Target (Mean)2.900 CAD

Upside (mean)-24.1%

Target Range2.900 CAD – 2.900 CAD

# Analysts1

Ownership

Shares Out.27.62M

Float14.94M

Insiders47.16%

Institutions0.00%

Short Interest

Short Ratio0.1d

Short % Out.0.01%

Shares Short3.73K

Short (prev mo.)3.88K

Technical

SMA 503.038 (+25.8%)

SMA 2002.185 (+74.9%)

Beta0.17

S&P 52W Chg16.45%

Avg Vol (30d)37.16K

Avg Vol (10d)48.63K

Technical Indicators

RSI (14)53.7

MACD0.3012

MACD Signal0.3574

MACD Hist.-0.0562

BB Upper4.571 CAD

BB Middle3.852 CAD

BB Lower3.132 CAD

BB Width37.36%

ATR (14)0.2657 CAD

Vol Ratio (20d)0.35x